Atlanta Trans Woman Sues Over Healthcare Denial

Keisha Williams sat in her apartment in East Atlanta last month, staring at the denial letter for the third time. Her insurer—a plan sold through Georgia's health marketplace—had rejected her request for coverage of hormone replacement therapy. The stated reason was categorical: the policy excluded all gender-affirming care as "experimental and not medically necessary." Williams, 34, had already waited two years to begin transition while saving money. She couldn't wait longer. On March 15, she filed suit in federal court against the insurer, represented by Lambda Legal, a national LGBTQ civil rights organization. The lawsuit is the first of its kind filed by an Atlanta resident directly challenging a Georgia-based insurance denial on these grounds. It arrives as medical organizations—including the American Medical Association, the Endocrine Society, and the American Psychological Association—have issued increasingly explicit statements affirming the medical necessity of gender-affirming care for transgender and nonbinary people. Yet state law in Georgia contains no explicit protections requiring insurers to cover such treatment. The gap between medical consensus and insurance policy has created a crisis for trans Georgians seeking care within the state. "Insurance denials aren't abstract policy disputes," said James Chen, Lambda Legal's Southeast regional counsel, in a statement provided to The Pink Pulse. "They're barriers that force people to choose between medical transition and financial ruin." Williams' case centers on a straightforward legal argument: the insurer's blanket exclusion violates the Affordable Care Act's prohibition on sex discrimination. The law forbids health plans from discriminating on the basis of sex. Lambda Legal contends that denying coverage for gender-affirming care—while covering equivalent treatments for cisgender patients—constitutes sex-based discrimination. The insurer's argument, according to court filings, is that the exclusion applies equally to all enrollees regardless of sex, and therefore does not discriminate. The distinction matters enormously. If courts accept Lambda Legal's framing, the ruling could force insurers across the Southeast to reconsider exclusions that have stood unchallenged for years. If the insurer prevails, it would reinforce the status quo in Georgia, where no state law mandates coverage and no court has yet ruled against an insurer on these grounds. Williams' medical history is unremarkable by clinical standards. She began seeing a gender-affirming therapist in 2021, completed a year of counseling, and received a letter of medical necessity from her therapist in early 2023. She then requested HRT through her primary care physician, who agreed to prescribe it. The insurer denied the request within two weeks. Williams appealed. The insurer denied the appeal, citing the same exclusion clause. "I had done everything right," Williams told The Pink Pulse in a phone interview. "I had the therapy. I had the medical recommendation. I had a doctor ready to treat me. And they just said no, because of a line in their policy." The financial stakes are real. Without insurance, HRT costs between $50 and $150 per month out of pocket—manageable for some, impossible for others. Williams works as a paralegal and initially tried to absorb the cost herself. After six months, the expense forced her to stop treatment and redirect the money toward rent. She remained off HRT for eight months before connecting with Lambda Legal through a referral from a local LGBTQ health nonprofit. Georgia's insurance landscape makes cases like Williams' more common than many realize. The state has no statute explicitly requiring coverage of gender-affirming care. Unlike California, New York, and several other states, Georgia has never passed legislation mandating such coverage. The absence of state law means insurers operating in Georgia face no legal obligation to cover HRT, surgical procedures, or mental health services related to gender transition—unless federal law intervenes. Lambda Legal has pursued similar cases in other states, winning in some federal circuits and losing in others. A 2019 case in the Eleventh Circuit Court of Appeals—which covers Georgia, Florida, and Alabama—resulted in a loss for transgender plaintiffs challenging a military health plan's exclusion. That precedent doesn't bind state insurance disputes, but it signals that the Southeast's federal courts have been skeptical of discrimination arguments in this context. Atlanta's trans population has developed informal networks to navigate these gaps. Several local nonprofits and clinics offer sliding-scale HRT prescriptions. Some trans residents travel to neighboring states where Medicaid covers gender-affirming care. Others rely on online pharmacies operating in legal gray areas. These workarounds keep people alive and moving forward, but they also create disparities: those with resources and knowledge find care; those without do not. The insurer, in a statement to The Pink Pulse, declined to comment on pending litigation. The company's broader position, stated in previous communications with advocacy groups, is that gender-affirming care remains too novel to mandate coverage and that further research is warranted before making it standard. Medical organizations have largely moved past that argument. The Endocrine Society's 2017 clinical practice guidelines, updated in 2020, describe HRT as evidence-based treatment with documented health benefits. The American Medical Association's 2021 position statement affirms that gender-affirming medical care improves mental health outcomes and reduces suicide risk among transgender people. These statements carry weight in federal court, where judges increasingly review medical consensus when evaluating coverage disputes. Williams' case will likely move slowly through federal court—discovery, summary judgment motions, possibly trial. A decision could take eighteen months or longer. In the meantime, Williams has resumed HRT through a local clinic's sliding-scale program, paying $40 per month instead of the full cost. She says the lawsuit matters less for her immediate situation than for what comes after. "There are trans people in Atlanta who can't afford forty dollars," she said. "If this case pushes insurance companies to cover care, that changes everything for them."